Caroline Litchfield
Director of Finance/CFO at IMMUNE DESIGN CORP
Net worth: 7 M $ as of 30/03/2024
Profile
Ms. Caroline A. Litchfield is a Chief Financial Officer & Director at Immune Design Corp. and a Chief Financial Officer & Executive Vice President at Merck & Co., Inc. She is on the Board of Directors at Immune Design Corp. Ms. Litchfield was previously employed as a Finance Director by Merck Sharp & Dohme Ltd. She received her undergraduate degree from the University of Leicester.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
MERCK & CO., INC.
0.00% | 13/02/2024 | 50,908 ( 0.00% ) | 7 M $ | 30/03/2024 |
Caroline Litchfield active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNE DESIGN CORP | Director of Finance/CFO | - |
| MERCK & CO., INC. | Director of Finance/CFO | 31/03/2021 |
Former positions of Caroline Litchfield
| Companies | Position | End |
|---|---|---|
| ORGANON & CO. | Director/Board Member | 30/05/2021 |
| FULFORD (INDIA) LIMITED | Director/Board Member | 29/01/2014 |
Organon Pharma (UK) Ltd.
 Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Director of Finance/CFO | 22/06/2009 |
Training of Caroline Litchfield
| University of Leicester | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| ORGANON & CO. | Health Technology |
| Private companies | 3 |
|---|---|
Fulford (India) Ltd.
 Fulford (India) Ltd. Pharmaceuticals: MajorHealth Technology Fulford (India) Ltd. engages in the wholesale of pharmaceutical and medical goods. Its products include speciality health care and fertility, oncology, quadriderm, elocon, elosalic, dipsalic, and emolene. The company was founded on March 2, 1948 and is headquartered in Mumbai, India. | Health Technology |
Organon Pharma (UK) Ltd.
Organon Pharma (UK) Ltd. Pharmaceuticals: MajorHealth Technology Organon Pharma (UK) Ltd. develops and manufactures pharmaceuticals. It offers osteoarthritis pain treatment Arcoxia, cardiovascular medication Cozaar, HIV drug Crixivan and asthma treatment Singulair. It operates a research center specializing in the development of central nervous system disorder such as Alzheimer's disease, depression, anxiety and migrane. The company was founded in 1953 and is headquartered in Hoddesdon, the United Kingdom. | Health Technology |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
- Stock Market
- Insiders
- Caroline Litchfield
